News

Iconovo AB: Quarterly Report Q1 2025
SIGNIFICANT EVENTS DURING 1 JANUARY - 31 MARCH 2025Iconovo and Lonza have entered a collaboration to develop spray-dried formulations of an intranasal biologic drug for Iconovo's proprietary intranasa ...
Fierce Pharma21h
Texas outsourcer in Lilly's compounded tirzepatide lawsuit hit with FDA warning letter
A Houston-based compounding pharmacy that was recently roped into Eli Lilly’s fight against knockoff GLP-1s has landed in the FDA’s crosshairs for the second time in less than a year. | The FDA has ...
Healio4h
Semaglutide adverse events named in nearly 25,000 ED visits in 2 years since approval
An estimated 24,499 people visited the ED for adverse events related to semaglutide in the 2 years after its approval for ...
News-Medical.Net on MSN8h
What’s behind Gen Z’s skepticism about Ozempic and Wegovy
A U.S. study of over 500 youth aged 14–24 found high awareness but widespread hesitation about using semaglutide for weight ...
The Healthy @Reader's Digest on MSN10h
What Is Ozempic Face? 2 Expert Doctors Explain Semaglutide Facial Changes
Highlights Semaglutide medications like Ozempic may cause facial changes. You can take steps to help minimize or prevent ...
PROCESS Worldwide20h
Top 20 Biopharmaceutical Co.’s Witness 6% Growth in Market Capitalization in Q1 2025
Global Data has revealed that the Top 20 Global Biopharmaceutical Companies have witnessed a 6 % growth in market ...